Skip to main content
Log in

Synthesis, characterization and pharmacological evaluation of (E)-N′-(substituted-benzylidene)isonicotinohydrazide derivatives as potent anticonvulsant agents

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A series of (E)-N′-(substituted-benzylidene)isonicotinohydrazide derivatives were synthesized by coupling it with different substituted aldehydes, acetophenone, and benzophenones in presence of absolute ethanol along with catalytic amount of glacial acetic acid. All the synthesized compound were confirmed and characterized by using various spectral technique like IR, 1H NMR, 13C NMR, and mass spectroscopy studies. Anticonvulsant evaluations of all the synthesized compounds were done using various seizures models like maximal electroshock-induced seizure (MES) and subcutaneous pentylenetetrazole (scPTZ) at a dose of 30, 100, and 300 mg/kg body weight and anticonvulsant activity was noted at 0.5 h and 4 h time intervals after the drug administration. Compound 1a (E)-N′-2-benzylidene isonicotinohydrazide, 1g (E)-N′-2-ethoxybenzylidene isonicotinohydrazide, 1k (E)-N′-3-flourobenzylidene isonicotinohydrazide and 3a (E)-N′-diphenylmethylene isonicotinohydrazide showed protection in MES model, which indicates that these compounds have the ability to prevent the spread of seizure at 300 mg/kg dose and showed protection at 0.5 h duration. Compound 3a was also found to be active in scPTZ screen at a dose of 300 mg/kg. In neurotoxicity screen, all the synthesized compounds were found non-toxic except compounds 1n, 2a, and 3b. Further compounds 1a, 1g, 1k, and 3a were also evaluated in the minimal clonic seizure model and exhibited potent anticonvulsant activity with lower neurotoxicity. Among all synthesized derivatives, analogue 3a was found to exhibit protection in MES and scPTZ seizure models. This study proved that isonicotinoyl hydrazides synthesized by condensing isoniazid with various aldehydes and ketones displayed moderate to potent anticonvulsant activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1

Similar content being viewed by others

References

  • Aggarwal N, Mishra P, Nagori BP, Aggarwal R, Jain J (2009) Anticonvulsant and neurotoxicity evaluation of Some N4 phenyl substituted pyridyl semicarbazones. Cent Nerv Syst Agents Med Chem 9:295–299

    PubMed  CAS  Google Scholar 

  • Angelusiu MA, Barbuceanu SF, Draghici C, Almajan GL (2010) New Cu (II), Co (II), Ni (II) complexes with aroyl-hydrazone based ligand. Synthesis, spectroscopic characterization and in vitro antibacterial evaluation. Eur J Med Chem 45:2055–2062. doi:10.1016/j.ejmech.2010.01.033

    Article  PubMed  CAS  Google Scholar 

  • Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217–227

    Article  PubMed  CAS  Google Scholar 

  • Curtis DR, Larsen KP, Kruger SJ, Kofoed H (1978) GABA Neurotransmitters: pharmacochemical biochemical and pharmacological aspects. Munksgaard, Copenhagen, pp 17–27

    Google Scholar 

  • Dimmock JR, Baker GB (1994) Anticonvulsant activities of 4-bromobenzaldehyde semicarbazone. Epilepsia 35:648–655. doi:10.1111/j.1528-1157.1994.tb02486

    Article  PubMed  CAS  Google Scholar 

  • Dimmock JR, Pandeya SN, Quail JW, Pugazhenthi U, Allen TM, Kao GY, Balzarini J, Declercq E (1995) Evaluation of the semicarbazones, thiosemicarbazones and bis-carbohydrazones of some aryl alicyclic ketones for anticonvulsant and other biological properties. Eur J Med Chem 30:303–314. doi:10.1016/0223-5234(96)88238-9

    Article  CAS  Google Scholar 

  • Dimmock JR, Puthucode RN, Smith JM, Hetherington M, Quail JW, Pugazhenthi U, Lechler T, Stables JP (1996) Aryloxy aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock dcreen. J Med Chem 39:3984–3997. doi:10.1021/jm9603025

    Article  PubMed  CAS  Google Scholar 

  • Dimmock JR, Sample HA, John S, Beazely MA, Abrams GD (1999) Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy) benzaldehyde semicarbazone after oral dosing to rats. Die Pharmazie 54:260–262

    PubMed  CAS  Google Scholar 

  • Duncan JS (2002) The promise of new antiepileptic drugs. Br J Clin Pharmacol 53:123–131. doi:10.1046/j.0306-5251.2001.01540

    Article  PubMed  CAS  Google Scholar 

  • Eadie MJ, Tyrer JH, Kutt H (1989) Anticonvulsant therapy: pharmacological basis and practice. Churchill Livingstone, Edinburgh

    Google Scholar 

  • Gajcy K, Kala JP, Fra BZ, Wojtasek C, Librowski T, Lochyn S (2010) Stereochemistry of terpene derivatives. Part 7: Novel rigidified amino acids from (+)-3-carene designed as chiral GABA analogues. Tetrahedron Asymmetr 21:2015–2020. doi:10.1016/j.tetasy.2010.06.026

    Article  CAS  Google Scholar 

  • Ghogare JG, Bhandari SV, Bothara KG, Madgulkar AR, Parashar GA, Sonawane BG, Inamdar PR (2010) Design, synthesis and pharmacological screening of potential anticonvulsant agents using hybrid approach. Eur J Med Chem 45:857–863. doi:10.1016/j.ejmech.2009.09.014

    Article  PubMed  CAS  Google Scholar 

  • Jones GL, Woodbury DM (1982) Anticonvulsant structure–activity relationships: historical development and probable causes of failure. Drug Dev Res 2:333–355

    Article  CAS  Google Scholar 

  • Kaushik D, Khan SA, Chawla G, Kumar S (2010) N’-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene]2/4-substituted hydrazides: synthesis and anticonvulsant activity. Eur J Med Chem 45:3943–3949. doi:10.1016/j.ejmech.2010.05.049

    Article  PubMed  CAS  Google Scholar 

  • Krall RJ, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978) Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19(4):409–428

    Article  PubMed  CAS  Google Scholar 

  • Kulandasamy R, Adhikari AV, Stables JP (2009a) Synthesis and anticonvulsant activity of some bishydrazone derived from 3,4-dipropyloxythiophene. Eur J Med Chem 44:3672–3679. doi:10.1016/j.ejmech.2009.02.009

    Article  PubMed  CAS  Google Scholar 

  • Kulandasamy R, Adhikari AV, Stables JP (2009b) A New class of anticonvulsant possessing 6 Hz activity: 3,4-Dialkyloxythiophene bishydrazones. Eur J Med Chem 44:4376–4384. doi:10.1016/j.ejmech.2009.05.026

    Article  PubMed  CAS  Google Scholar 

  • Kulig K, Wieckowski K, Wieckowski A, Gajda J, Pochwat B, Hofner GC, Wanner KT, Malawska B (2011) Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors. Eur J Med Chem 46:183–190. doi:10.1016/j.ejmech.2010.11.001

    Article  PubMed  CAS  Google Scholar 

  • Loscher W, Bartholini G, Bossi L, Lloyd KG, Morselli PL (1985) Epilepsy and GABA receptor agonists: basic and therapeutic research. L.E.R.S. monograph series. Raven Press, New York, pp 109–119

    Google Scholar 

  • Lourenco MCS, Souza MVND, Pinheiro AC, Ferreira MDL, Goncalves RSB, Nogueira TCM, Peralta MA (2007) Evaluation of anti-tubercular activity of nicotinic and isoniazid analogue. Arkivoc 15:181–191

    Google Scholar 

  • Lourenco MCDS, Ferreira MDL, Souza MVND, Peralta MA, Vasconcelos TRA, Henriques MDGM (2008) Synthesis and anti-mycobacterial activity of (E)-N’-(substituted-benzylidene)isonicotinohydrazide derivatives. Eur J Med Chem 43:1344–1347. doi:10.1016/j.ejmech.2007.08.003

    Article  PubMed  CAS  Google Scholar 

  • Pandeya SN, Mishra V, Singh PN, Rupainwar DC (1998) Anticonvulsant activity of thioureido derivatives of acetophenone semicarbazone. Pharmacol Res 37:17–22

    Article  PubMed  CAS  Google Scholar 

  • Pandeya SN, Raja AS, Stables JP (2002) Synthesis of isatin semicarbazones as potential anticonvulsants. Role of hydrogen bonding. J Pharm Pharm Sci 5:266–271

    PubMed  CAS  Google Scholar 

  • Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferburg HJ, Scoville B (1984) Antiepileptic drug development program. Cleve Clin Q 51:293–305

    PubMed  CAS  Google Scholar 

  • Puthucode RN, Pugazhenthi U, Quail JW, Stables JP, Dimmock JR (1998) Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones. Eur J Med Chem 33:595–607. doi:10.1016/S0223-5234(98)80018-4

    Article  Google Scholar 

  • Sinha R, Sara UVS, Khosa RL, Stables J, Jainendra J (2010) Nicotinic acid hydrazone: a novel anticonvulsant pharmacophore. Med Chem Res. doi:10.1007/s0004–010-9396–0

  • Wong MG, Dejina JA, Andrews PR (1986) Conformational analysis of clinically active anticonvulsant drugs. J Med Chem 29:562–572

    Article  PubMed  CAS  Google Scholar 

  • Yogeeswari P, Sriram D, Pandeya SN, Stables JP (2004) 4-Sulphamoyl phenyl semicarbazones with anticonvulsant activity. IL Farmaco 59:609–613. doi:10.1016/j.farmac.2004.01.009

    Article  PubMed  CAS  Google Scholar 

  • Yogeeswari P, Sriram D, Veena V, Kavya R, Rakhra K, Mehta S, Raghuvendran JV, Thirumurugan R, Stables JP (2005) Synthesis of aryl semicarbazones as potential anticonvulsant agents. Biomed Pharmacother 59:51–55. doi:10.1016/j.biopha.2004.04.013

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aakash Deep.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malhotra, M., Monga, V., Sharma, S. et al. Synthesis, characterization and pharmacological evaluation of (E)-N′-(substituted-benzylidene)isonicotinohydrazide derivatives as potent anticonvulsant agents. Med Chem Res 21, 2145–2152 (2012). https://doi.org/10.1007/s00044-011-9739-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-011-9739-5

Keywords

Navigation